243 related articles for article (PubMed ID: 32194154)
1. The role of HLA-DP mismatches and donor specific HLA-DP antibodies in kidney transplantation: a case series.
Daniëls L; Claas FHJ; Kramer CSM; Senev A; Vanden Driessche M; Emonds MP; Van Laecke S; Hellemans R; Abramowicz D; Naesens M
Transpl Immunol; 2021 Apr; 65():101287. PubMed ID: 32194154
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
[TBL] [Abstract][Full Text] [Related]
4. Eplet Mismatch Load and
Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
[TBL] [Abstract][Full Text] [Related]
5. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
[TBL] [Abstract][Full Text] [Related]
6. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
7. Correlation of Luminex-Based Single Antigen Based Results With Complement-Dependent Cytotoxicity Crossmatch and Flow Cytometry Crossmatch Results: A Single-Center Experience From Istanbul.
Oguz SR; Sinangil A; Barlas S; Ciftci HS; Ulusoy E; İzgi DK; Ogret Y; Ecder T; Akin B
Transplant Proc; 2023 Mar; 55(2):303-308. PubMed ID: 36890054
[TBL] [Abstract][Full Text] [Related]
8. Early acute antibody-mediated rejection of a negative flow crossmatch 3rd kidney transplant with exclusive disparity at HLA-DP.
Mierzejewska B; Schroder PM; Baum CE; Blair A; Smith C; Duquesnoy RJ; Marrari M; Gohara A; Malhotra D; Kaw D; Liwski R; Rees MA; Stepkowski S
Hum Immunol; 2014 Aug; 75(8):703-8. PubMed ID: 24755353
[TBL] [Abstract][Full Text] [Related]
9. Low-MFI (median fluorescence intensity) pre-transplant DSA (donor specific antibodies) leading to anamnestic antibody mediated rejection in live-related donor kidney transplantation.
Chauhan R; Tiwari AK; Aggarwal G; Gowri Suresh L; Kumar M; Bansal SB
Transpl Immunol; 2023 Dec; 81():101931. PubMed ID: 37730185
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of pretransplant HLA class II donor-specific antibodies in renal transplantation patients with negative T-cell cytotoxicity crossmatches.
Song EY; Lee YJ; Hyun J; Kim YS; Ahn C; Ha J; Kim SJ; Park MH
Ann Lab Med; 2012 Mar; 32(2):139-44. PubMed ID: 22389881
[TBL] [Abstract][Full Text] [Related]
11. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
Yamanaga S; Watarai Y; Yamamoto T; Tsujita M; Hiramitsu T; Nanmoku K; Goto N; Takeda A; Morozumi K; Katayama A; Saji H; Uchida K; Kobayashi T
Hum Immunol; 2013 Sep; 74(9):1111-8. PubMed ID: 23792054
[TBL] [Abstract][Full Text] [Related]
12. Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation.
Malheiro J; Tafulo S; Dias L; Martins LS; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
Transpl Immunol; 2015 Mar; 32(2):66-71. PubMed ID: 25661873
[TBL] [Abstract][Full Text] [Related]
13. Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation.
Riethmüller S; Ferrari-Lacraz S; Müller MK; Raptis DA; Hadaya K; Rüsi B; Laube G; Schneiter G; Fehr T; Villard J
Transplantation; 2010 Jul; 90(2):160-7. PubMed ID: 20658760
[TBL] [Abstract][Full Text] [Related]
14. Impact of pre-transplant donor specific antibodies detected by Luminex with negative microlymphocytotoxicity assay and flow crossmatch in live-related renal transplant recipients.
Abbas K; Aziz T; Musharaf W; Mubarak M; Zafar MN
Clin Transplant; 2023 May; 37(5):e14935. PubMed ID: 36799009
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J
Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088
[TBL] [Abstract][Full Text] [Related]
16. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation.
Morris GP; Phelan DL; Jendrisak MD; Mohanakumar T
Hum Immunol; 2010 Mar; 71(3):268-73. PubMed ID: 20074605
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of Luminex-based donor-specific antibody mean fluorescence intensity values with complement-dependent cytotoxicity & flow crossmatch results in live donor renal transplantation.
Baranwal AK; Bhat DK; Goswami S; Agarwal SK; Kaur G; Kaur J; Mehra N
Indian J Med Res; 2017 Feb; 145(2):222-228. PubMed ID: 28639599
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of virtual crossmatch (VXM) prediction of physical crossmatch (PXM) results of donor specific antibody (DSA) in routine pretransplant settings-a single-center experience.
Olszowska-Zaremba N; Zagożdżon R; Gozdowska J
Transpl Immunol; 2022 Jun; 72():101583. PubMed ID: 35314352
[TBL] [Abstract][Full Text] [Related]
19. Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.
Schwaiger E; Eskandary F; Kozakowski N; Bond G; Kikić Ž; Yoo D; Rasoul-Rockenschaub S; Oberbauer R; Böhmig GA
Nephrol Dial Transplant; 2016 Aug; 31(8):1342-51. PubMed ID: 27190362
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]